Skip to Main Content
OUTSOURCE EVERYTHING BUT THE GENIUS™

Go to Main Navigation

Challenges

Showing 1-10 of 43 posts
April 4

We sat down with Meaghan Loy, Category Director, In Vivo Services at Scientist.com, to discuss her perspective on clinical trials and to learn more...

Nov 18, 2021

It’s now well known that biopharmaceutical companies are increasingly turning to third-party suppliers to support their research and development...

Nov 16, 2021

Meaghan Loy, Category Director of In Vivo Services at Scientist.com and member of the North American 3Rs Collaborative Board of Directors...

Oct 29, 2021

The field of preclinical oncology research is being hit by a new wave of innovation, specifically innovation in disease model sourcing for drug...

Oct 7, 2021

Biotechnology companies aim to develop products and technologies that can solve the many health-related problems that plague our world today. The...

Jul 22, 2021

By Maria Menikou, Category Director, Human Biological Samples at Scientist.com and Gina Dunne Smith, Executive Director at International Institute...

Jun 19, 2020

Over the past weeks, Scientist.com has been working hard to listen, learn and implement short-term and long-term changes regarding diversity within...

Jun 4, 2020

The first occurrence of human infections of the novel Coronavirus (COVID-19) was recognized in Wuhan, China. Due to its fast spreading and...

Mar 3, 2020

Though much of the world is hearing about them for the first time, coronaviruses are a large family of related viruses responsible for respiratory...

Apr 23, 2018

Chilling stories and movie plots depicting a hidden, global black market for human biospecimen such as organs, tissue and other elements of the...